Overt and Incomplete (Silent) Cerebral Infarction in Sickle Cell Anemia: Diagnosis and Management

Hematology/Oncology Clinics of North America - Tập 19 Số 5 - Trang 839-855 - 2005
W. Eric Wong1, Darleen Powars2
1Department of Pediatrics, Division of Hematology/Oncology, Children's Hospital Los Angeles, Keck School of Medicine at the University of Southern California, Los Angeles, CA, USA.
2Department of Pediatrics, Division of Hematology/Oncology, Women's & Children's Hospital, Keck School of Medicine at the University of Southern California, 1240 North Mission Road, Room L902, Los Angeles, CA 90033, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Pegelow, 2001, Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity, Arch Neurol, 58, 2017, 10.1001/archneur.58.12.2017

Prengler, 2002, Sickle cell disease: the neurological complications, Ann Neurol, 51, 543, 10.1002/ana.10192

Grubb, 1998, Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion, JAMA, 280, 1055, 10.1001/jama.280.12.1055

Ohene-Frempong, 1998, Cerebrovascular accidents in sickle cell disease: rates and risk factors, Blood, 91, 228

Powars, 1978, The natural history of stroke in sickle cell disease, Am J Med, 65, 461, 10.1016/0002-9343(78)90772-6

Adams, 2001, Sickle cell and the brain, Hematology (Am Soc Hematol Educ Program), 31, 10.1182/asheducation-2001.1.31

Wang, 2000, Multicenter comparison of magnetic resonance imaging and transcranial Doppler ultrasonography in the evaluation of the central nervous system in children with sickle cell disease, J Pediatr Hematol Oncol, 22, 335, 10.1097/00043426-200007000-00010

Steen, 2003, Brain imaging findings in pediatric patients with sickle cell disease, Radiology, 228, 216, 10.1148/radiol.2281020943

Garcia, 1996, Ischemic stroke and incomplete infarction, Stroke, 27, 761, 10.1161/01.STR.27.4.761

Koshy, 1990, Vascular lesions in the central nervous system in sickle cell disease (neuropathology), JAAMP, 1, 71

Powars, 1999, Cerebral vasculopathy in sickle cell anemia: diagnostic contribution of positron emission tomography, Blood, 93, 71

Driscoll, 2003, Stroke risk in siblings with sickle cell anemia, Blood, 101, 2401, 10.1182/blood.V101.6.2401

Hoppe, 2003, Distinct HLA associations by stroke in children with sickle cell anemia, Blood, 101, 2865, 10.1182/blood-2002-09-2791

Hsu, 2003, Alpha thalassemia is associated with decreased risk of abnormal transcranial Doppler ultrasonography in children with sickle cell anemia, J Pediatr Hematol Oncol, 25, 622, 10.1097/00043426-200308000-00007

Huang, 2000, Transport of N-acetylaspartate by the Na+-dependent high-affinity dicarboxylate transporter NaDC3 and its relevance to the expression of the transporter in the brain, Pharmacology, 295, 392

Steen, 2005, Abnormally high levels of brain N-acetylaspartate in children with sickle cell disease, AJNR Am J Neuroradiol, 26, 463

Miller, 2000, Prediction of adverse outcomes in children with sickle cell disease: a report from the Cooperative Study (CSSCD), N Engl J Med, 342, 83, 10.1056/NEJM200001133420203

Glauser, 1995, Accuracy of neurologic examination and history in detecting evidence of MRI-diagnosed cerebral infarctions in children with sickle cell hemoglobinopathy, J Child Neurol, 10, 88, 10.1177/088307389501000203

Wang, 1998, Abnormalities of the central nervous system in very young children with sickle cell anemia, J Pediatr, 132, 994, 10.1016/S0022-3476(98)70397-X

Miller, 2001, Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease, J Pediatr, 139, 385, 10.1067/mpd.2001.117580

Scothorn, 2002, Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke, J Pediatr, 140, 348, 10.1067/mpd.2002.122498

Kirkham, 2001, Perfusion magnetic resonance abnormalities in patients with sickle cell disease, Ann Neurol, 49, 477, 10.1002/ana.97

Dobson, 2002, Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events, Blood, 99, 3144, 10.1182/blood.V99.9.3144

Swift, 1989, Neuropsychologic impairment in children with sickle cell anemia, An Pediatr (Barc), 84, 1077

Adams, 2001, Stroke prevention and treatment in sickle cell disease, Arch Neurol, 58, 565, 10.1001/archneur.58.4.565

Quinn, 2004, Survival of children with sickle cell disease, Blood, 103, 4023, 10.1182/blood-2003-11-3758

Powars, 2000, Management of cerebral vasculopathy in children with sickle cell anaemia, Br J Haematol, l108, 666, 10.1046/j.1365-2141.2000.01912.x

Earley, 1998, Stroke in children and sickle-cell disease: Baltimore-Washington Cooperative Young Stroke Study, Neurology, 51, 169, 10.1212/WNL.51.1.169

Gabis, 2002, Time lag to diagnosis of stroke in children, An Pediatr (Barc), 110, 924

Katz, 2002, Knowledge of stroke risk, signs of stroke, and the need for stroke education among children with sickle cell disease and their caregivers, Ethn Health, 7, 115, 10.1080/1355785022000038597

Armstrong, 1996, Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease, An Pediatr (Barc), 97, 864

Craft, 1993, Neuropsychologic effects of stroke in children with sickle cell anemia, J Pediatr, 123, 712, 10.1016/S0022-3476(05)80844-3

Bernaudin, 2000, Multicenter prospective study of children with sickle cell disease: radiographic and psychometric correlation, J Child Neurol, 15, 333, 10.1177/088307380001500510

Schatz, 2002, Lesion burden and cognitive morbidity in children with sickle cell disease, J Child Neurol, 17, 891, 10.1177/08830738020170122401

Pegelow, 2002, Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease, Blood, 99, 3014, 10.1182/blood.V99.8.3014

Adams, 2000, Lessons from the stroke prevention trial in sickle cell anemia (STOP) study, J Child Neurol, 15, 344, 10.1177/088307380001500511

Abboud, 2004, Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study, Blood, 103, 2822, 10.1182/blood-2003-06-1972

Vermeer, 2003, Silent brain infarcts and the risk of dementia and cognitive decline, N Engl J Med, 348, 1215, 10.1056/NEJMoa022066

Moran, 1998, Sickle cell disease: imaging of cerebrovascular complications, Radiology, 206, 311, 10.1148/radiology.206.2.9457180

Mullins, 2002, CT and conventional and diffusion-weighted MR imaging in acute stroke: study in 691 patients at presentation to the emergency department, Radiology, 224, 356, 10.1148/radiol.2242010873

Moritani, 2004, Sickle cell cerebrovascular disease: usual and unusual findings on MR imaging and MR angiography, Clin Imag, 28, 173, 10.1016/S0899-7071(03)00121-9

Steen, 1998, Quantitative MRI of the brain in children with sickle cell disease reveals abnormalities unseen by conventional MRI, J Magn Reson Imaging, 8, 535, 10.1002/jmri.1880080304

Crisostomo, 2003, Detection of diffusion-weighted MRI abnormalities in patients with transient ischemic attack: correlation with clinical characteristics, Stroke, 34, 932, 10.1161/01.STR.0000061496.00669.5E

Schaefer, 2003, Assessing tissue viability with MR diffusion and perfusion imaging, AJNR Am J Neuroradiol, 24, 436

Kandeel, 1996, Comparison of magnetic resonance angiography and conventional angiography in sickle cell disease: clinical significance and reliability, Neuroradiology, 38, 409, 10.1007/BF00607263

Adams, 2004, Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study, Blood, 103, 3689, 10.1182/blood-2003-08-2733

Venketasubramanian, 1994, Middle cerebral artery velocity changes during transfusion in sickle cell anemia, Stroke, 25, 2153, 10.1161/01.STR.25.11.2153

Noguchi, 1995, Acute subarachnoid hemorrhage: MR imaging with fluid-attenuated inversion recovery pulse sequences, Radiology, 196, 773, 10.1148/radiology.196.3.7644642

Witt, 2003, Induction of fetal hemoglobin expression by the histone-deacetylase inhibitor apicidin, Blood, 101, 2001, 10.1182/blood-2002-08-2617

Rogers, 2004, Expanding the role of hydroxyurea in children with sickle cell disease, J Pediatr, 145, 287, 10.1016/j.jpeds.2004.06.032

Brott, 2000, Treatment of acute ischemic stroke, N Engl J Med, 343, 710, 10.1056/NEJM200009073431007

Scheidtmann, 2001, Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomized, double-blind study, Lancet, 358, 787, 10.1016/S0140-6736(01)05966-9

Schoning, 1996, Age dependence of total cerebral blood flow volume from childhood to adulthood, J Cereb Blood Flow Metab, 16, 827, 10.1097/00004647-199609000-00007

Huttenlocher, 1984, Cerebral blood flow in sickle cerebrovascular disease, An Pediatr (Barc), 73, 615

Raj, 2004, Assessment of cerebral tissue oxygenation in patients with sickle cell disease: effect of transfusion therapy, J Pediatr Hematol Oncol, 26, 279, 10.1097/00043426-200405000-00004

Buchanan, 1983, Recurrent cerebral ischemia during hypertransfusion therapy in sickle cell anemia, J Pediatr, 103, 921, 10.1016/S0022-3476(83)80716-1

Pegelow, 1995, Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions, J Pediatr, 126, 896, 10.1016/S0022-3476(95)70204-0

Russell, 1984, Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease, Blood, 63, 162, 10.1182/blood.V63.1.162.162

Cohen, 1992, A modified transfusion program for prevention of stroke in sickle cell disease, Blood, 79, 1657, 10.1182/blood.V79.7.1657.1657

Olivieri, 2001, Progression of iron overload in sickle cell disease, Semin Hematol, 38, 57, 10.1016/S0037-1963(01)90060-5

Ware, 1999, Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with sickle cell disease, Blood, 94, 3022, 10.1182/blood.V94.9.3022

Sumoza, 2002, Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA), Am J Hematol, 71, 161, 10.1002/ajh.10205

Zimmerman, 2004, Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease, Blood, 103, 2039, 10.1182/blood-2003-07-2475

Steinberg, 2003, Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment, JAMA, 289, 1645, 10.1001/jama.289.13.1645

Rana, 1997, Discontinuation of long-term transfusion therapy in patients with sickle cell disease and stroke, J Pediatr, 131, 757, 10.1016/S0022-3476(97)70108-2

Ware, 2004, Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy, J Pediatr, 145, 346, 10.1016/j.jpeds.2004.04.058

Wang, 2001, A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia, J Pediatr, 139, 790, 10.1067/mpd.2001.119590

Jackson, 2003, Functional cerebral reorganization following motor sequence learning through mental practice with motor imagery, Neuroimage, 20, 1171, 10.1016/S1053-8119(03)00369-0

Stevens, 2003, Using motor imagery in the rehabilitation of hemiparesis, Arch Phys Med Rehabil, 84, 1090, 10.1016/S0003-9993(03)00042-X

Taub, 1999, Constraint-induced movement therapy: a new family of techniques with broad application to physical rehabilitation. A clinical review, J Rehab Res Dev, 36, 237

Winstein, 2003, Motor control and learning principles for rehabilitation of upper limb movements after brain injury, 77

van der Lee, 1999, Forced use of the upper extremity in chronic stroke patients: results from a single-blind randomized clinical trial, Stroke, 30, 2369, 10.1161/01.STR.30.11.2369

Gladstone, 2000, Enhancing recovery after stroke with noradrenergic pharmacotherapy: a new frontier?, Can J Neurol Sci, 27, 97, 10.1017/S0317167100052173